PDE5A and erectile dysfunction: Subsequently developed PDE-5 inhibitor, tadalafil, has a longer half-life and has been shown in studies of erectile dysfunction to be safe and effective with daily oral administration.17 Tadalafil was tested by Oh et al15 using a rat model with a local injection of the drug into the flap and demonstrated a significant improvement in random pattern flap survival.